FDA Confers Emergency Use Authorization on Roche’s Cobas SARS-CoV-2 Test
The test is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples from patients who meet COVID-19 clinical and/or epidemiological criteria for testing.
Read More